Latest Breaking News On - Mihael polymeropoulos - Page 1 : comparemela.com

Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript February 7, 2024 Vanda Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Jeannie and I will be your conference operator today. At this time, […]

Tim williamsMihael polymeropoulosKevin moranQuality essential oil brandsFederal securitiesRisk factorsFinancial conditionGeneral counselNew drug applicationAnda pharmaceuticals incMihael polymeropoulosTim williamsFinancial resultsConference operator

Vanda stock jumps on $100M license deal for MS drug from J&J unit (NASDAQ:VNDA)

Vanda stock jumps on $100M license deal for MS drug from J&J unit (NASDAQ:VNDA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Mihael polymeropoulosHealth canadaVanda pharmaceuticalsSanofi genzyme

Vanda Pharma stock rises after FDA accepts gastroparesis drug for review (NASDAQ:VNDA)

Vanda Pharma stock rises after FDA accepts gastroparesis drug for review (NASDAQ:VNDA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Mihael polymeropoulosVanda pharmaEli lillyExpanded access

Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Q2 2023 Earnings Call Transcript

Operator: Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2023 Vanda Pharmaceuticals Inc. Earnings Call.

United statesNew jerseyMihael polymeropoulosMihaelh polymeropoulosTim williamsAndrew tsaiKevin moranCircuit courtVanda pharmaceuticals incVanda pharmaceuticalsCall transcript julyChief financialVanda pharmaceuticalChief executive officerRisk factorsFinancial condition

Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Q1 2023 Earnings Call Transcript

Operator: Good afternoon. My name is David and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Q1 2023 Vanda Pharmaceuticals Inc.

United statesKevin moranTimothy williamsTim williamsMihael polymeropoulosVanda pharmaceuticalsDelaware district courtVanda pharmaceuticals incCircuit courtDc district courtFourth circuit courtCourt circuitCall transcript mayEarnings conferenceVanda pharmaceuticalChief financial officer